Krystal Biotech, Inc. (KRYS) Corporate Subsidiaries
Krystal Biotech, Inc. (KRYS) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: KRYS
CIK: 1711279
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerMaria Blohm
Audit LocationPittsburgh, Pennsylvania, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-15 | 2026-10-15 | 8-K | 0001711279-26-000064 | View SEC Doc Filr Page |
| 4 | 2026-09-16 | 2026-09-14 | FORM 4 | 0001209059-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-09-16 | 2026-09-14 | FORM 4 | 0001852880-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-09-16 | 2026-09-14 | FORM 4 | 0001967722-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-09-16 | 2026-09-14 | FORM 4 | 0001836440-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-09-16 | 2026-09-14 | FORM 4 | 0001711279-26-000060 | View SEC Doc Filr Page |
| 4 | 2026-09-16 | 2026-09-14 | FORM 4 | 0001532023-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-09-04 | 2026-09-04 | FORM 4 | 0001298711-26-000009 | View SEC Doc Filr Page |
| 4 | 2026-09-04 | 2026-09-04 | FORM 4 | 0001298709-26-000011 | View SEC Doc Filr Page |
| 144 | 2026-09-04 | — | 144 Filing | 0001950047-26-009149 | View SEC Doc Filr Page |
| 144 | 2026-09-04 | — | 144 Filing | 0001950047-26-009148 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-14 | FORM 4 | 0001209059-26-000006 | View SEC Doc Filr Page |
| 144 | 2026-08-14 | — | 144 Filing | 0001958244-26-000513 | View SEC Doc Filr Page |
| 8-K | 2026-08-03 | 2026-08-03 | 8-K | 0001711279-26-000058 | View SEC Doc Filr Page |
| 10-Q | 2026-08-03 | 2026-06-30 | 10-Q | 0001711279-26-000057 | View SEC Doc Filr Page |
| 8-K | 2026-07-21 | 2026-07-21 | 8-K | 0001711279-26-000050 | View SEC Doc Filr Page |
| 4 | 2026-06-26 | 2026-06-25 | FORM 4 | 0002114900-26-000009 | View SEC Doc Filr Page |
| 144 | 2026-06-25 | — | 144 Filing | 0001959173-26-004871 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | FORM 4 | 0001298711-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | FORM 4 | 0001298709-26-000009 | View SEC Doc Filr Page |
| 144 | 2026-06-04 | — | 144 Filing | 0001950047-26-005653 | View SEC Doc Filr Page |
| 144 | 2026-06-04 | — | 144 Filing | 0001950047-26-005652 | View SEC Doc Filr Page |
| 4 | 2026-05-27 | 2026-05-26 | FORM 4 | 0002114900-26-000006 | View SEC Doc Filr Page |
| 144 | 2026-05-26 | — | 144 Filing | 0001959173-26-003960 | View SEC Doc Filr Page |
| 8-K | 2026-05-20 | 2026-05-15 | 8-K | 0001711279-26-000047 | View SEC Doc Filr Page |